Cargando…

Glioblastoma cell differentiation trajectory predicts the immunotherapy response and overall survival of patients

Glioblastoma (GBM) is the most common and lethal primary brain tumor. In this study, we aimed to investigate the differentiation states of GBM cells and their clinical relevance. Integrated single-cell RNA-sequencing (scRNA-seq) data and bulk RNA-seq data from GBM samples were used for analysis. Two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zihao, Guo, Xiaopeng, Gao, Lu, Wang, Yu, Ma, Wenbin, Xing, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585071/ https://www.ncbi.nlm.nih.gov/pubmed/32957084 http://dx.doi.org/10.18632/aging.103695

Ejemplares similares

Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic Analysis
por: Wang, Zihao, et al.
Publicado: (2020)

A novel hypoxic tumor microenvironment signature for predicting the survival, progression, immune responsiveness and chemoresistance of glioblastoma: a multi-omic study
por: Wang, Zihao, et al.
Publicado: (2020)

Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients
por: Wang, Zihao, et al.
Publicado: (2021)

Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma
por: Wang, Zihao, et al.
Publicado: (2019)

Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
por: Wang, Zihao, et al.
Publicado: (2020)

Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data
por: Wang, Zihao, et al.
Publicado: (2020)

The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness
por: Wang, Zihao, et al.
Publicado: (2020)

The radiosensitivity index predicts for overall survival in glioblastoma
por: Ahmed, Kamran A., et al.
Publicado: (2015)

B7-H3 in Brain Malignancies: Immunology and Immunotherapy
por: Guo, Xiaopeng, et al.
Publicado: (2023)

A Novel Extracellular Matrix Gene-Based Prognostic Model to Predict Overall Survive in Patients With Glioblastoma
por: Qian, Chen, et al.
Publicado: (2022)

Comprehensive In Silico Analysis of a Novel Serum Exosome-Derived Competitive Endogenous RNA Network for Constructing a Prognostic Model for Glioblastoma
por: Wang, Zihao, et al.
Publicado: (2021)

Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma
por: Beig, Niha, et al.
Publicado: (2018)

Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma
por: Hu, Ji-liang, et al.
Publicado: (2019)

Overall Survival Prediction in Glioblastoma With Radiomic Features Using Machine Learning
por: Baid, Ujjwal, et al.
Publicado: (2020)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
por: Zheng, Susu, et al.
Publicado: (2021)

Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
por: Krebs, Franziska K., et al.
Publicado: (2021)

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022)

Machine Learning and Radiomic Features to Predict Overall Survival Time for Glioblastoma Patients
por: Chato, Lina, et al.
Publicado: (2021)

A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma
por: Zhang, Chaocai, et al.
Publicado: (2021)

Safety of Withholding Perioperative Hydrocortisone for Patients With Pituitary Adenomas With an Intact Hypothalamus-Pituitary-Adrenal Axis: A Randomized Clinical Trial
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Colorectal Cancer Cell Differentiation Trajectory Predicts Patient Immunotherapy Response and Prognosis
por: Qin, Yuling, et al.
Publicado: (2022)

Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma
por: Li, Longqing, et al.
Publicado: (2022)

Functional connectivity within glioblastoma impacts overall survival
por: Daniel, Andy G S, et al.
Publicado: (2020)

Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma
por: Zhu, Xiaopeng, et al.
Publicado: (2021)

Inflammatory aging clock: A cancer clock to characterize the patients’ subtypes and predict the overall survival in glioblastoma
por: Zhu, Lei, et al.
Publicado: (2022)

Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma
por: Oshima, Sonoko, et al.
Publicado: (2023)

A Complement-Related Gene Signature for Predicting Overall Survival and Immunotherapy Efficacy in Sarcoma Patients
por: Zhang, Lin, et al.
Publicado: (2022)

Leukopenia is a biomarker for effective temozolomide dosing and predicts overall survival of patients with glioblastoma
por: Ho, K. Grace, et al.
Publicado: (2020)

Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
por: Li, Yuanfang, et al.
Publicado: (2023)

Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer
por: Xiang, Renshen, et al.
Publicado: (2021)

Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients
por: Carr, Matthew T., et al.
Publicado: (2019)

Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma
por: Wang, Shouchao, et al.
Publicado: (2022)

Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients
por: Cheng, Lijing, et al.
Publicado: (2021)

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma
por: Ma, Kexin, et al.
Publicado: (2019)

PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma
por: Yuile, Alexander, et al.
Publicado: (2023)

Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
por: Qiu, Jun, et al.
Publicado: (2023)

A prognostic nomogram for predicting overall survival in colorectal mucinous adenocarcinoma patients based on the SEER database
por: Wu, Qian, et al.
Publicado: (2023)

Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma
por: He, Xia, et al.
Publicado: (2019)

The Nomogram Model Predicting Overall Survival and Guiding Clinical Decision in Patients With Glioblastoma Based on the SEER Database
por: Li, Hongjian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mmsgtk5s4k11d84nb845tnsbff